Literature DB >> 27315374

Oncogenic PKCι decides tumor-initiating cell fate.

Alan P Fields1, Syed A Ali1, Nicole R Murray1.   

Abstract

Entities:  

Keywords:  asymmetric cell division; cell fate decisions; lung cancer; protein kinase Cι; stemness; therapeutic intervention; tumor-initiating cells

Mesh：

Substances：

Year:  2016        PMID： 27315374      PMCID： PMC5026803          DOI： 10.1080/15384101.2016.1194624

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  8 in total

Review 1.  Epithelial cell polarity, stem cells and cancer.

Authors:  Fernando Martin-Belmonte; Mirna Perez-Moreno
Journal:  Nat Rev Cancer       Date:  2011-12-15       Impact factor: 60.716

Review 2.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 3.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

4.  A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients.

Authors:  Aminah Jatoi; Carmen Radecki Breitkopf; Nathan R Foster; Matthew S Block; Megan Grudem; Andrea Wahner Hendrickson; Rachel E Carlson; Brigitte Barrette; Nina Karlin; Alan P Fields
Journal:  Oncology       Date:  2014-12-06       Impact factor: 2.935

5.  The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.

Authors:  Verline Justilien; Michael P Walsh; Syed A Ali; E Aubrey Thompson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

6.  Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.

Authors:  Syed A Ali; Verline Justilien; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

7.  Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer.

Authors:  Aaron S Mansfield; Alan P Fields; Aminah Jatoi; Yingwei Qi; Alex A Adjei; Charles Erlichman; Julian R Molina
Journal:  Anticancer Drugs       Date:  2013-11       Impact factor: 2.248

Review 8.  Asymmetric cell division and template DNA co-segregation in cancer stem cells.

Authors:  Sharon R Pine; Wenyu Liu
Journal:  Front Oncol       Date:  2014-08-21       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.